Get started
Author

Asuman Çelebi

Observed names: A. Çelebi, Asuman Celebi, Asuman Çelebi
ORCID: 0000-0003-0960-6351
Observed ORCID: 0000-0003-0960-6351
OpenAlex ID: A5040295139
Glycopolymer and Poly(β-amino ester)-Based Amphiphilic Block Copolymer as a Drug Carrier
2022 · Elif L. Sahkulubey Kahveci, Muhammet U. Kahveci, et al. · Biomacromolecules · 32
A novel BH3 mimetic Bcl-2 inhibitor promotes autophagic cell death and reduces in vivo Glioblastoma tumor growth
2022 · Seyma Calis, Berna Dogan, et al. · Cell Death Discovery · 21
PDF
The investigation of hyaluronic acid and hyaluronidase‐1 levels as tumour marker in larynx cancer
2019 · Hakkı Caner İnan, Murat Yener, et al. · Clinical Otolaryngology · 6
Silencing of Wwox Increases Nuclear Import of Dvl proteins in Head and Neck Cancer
2020 · Asuman Celebi, Ceren Orhan, et al. · Journal of Cancer · 5
PDF
In vitro evaluation of the therapeutic efficacy of Moringa oleifera and oxaliplatin in 3D printed polycaprolactone/gelatin implantable patches: A potential strategy for overcoming drug resistance in colorectal cancer treatment
2025 · Hasan Ege, Gozde Enguven, et al. · International Journal of Biological Macromolecules · 4
Synthesis of Tryptamine-Thiazolidin-4-one Derivatives and the Combined In Silico and In Vitro Evaluation of their Biological Activity and Cytotoxicity
2024 · Seher Aydın, Yavuz Ergün, et al. · ACS Omega · 3
Investigation of Toll-like Receptor-2, -3 and -4 Gene Expressions in Larynx Squamous Cell Carcinoma
2022 · Çağlar Eker, Hakkı Caner İnan, et al. · Turkish Archives of Otorhinolaryngology · 2
PDF
No Tumor Suppressor Role for LKB1 in Prostate Cancer
2021 · Hikmet Koseoglu, Asuman Celebi, et al. · DNA and Cell Biology · 2
Targeting BCL-2 through Deep Learning-Based Drug Repurposing: A Multimodal Approach Combining Diffusion-Based Generative Modeling, Neural Relational Inference, and In Vitro Validation
2026 · Ehsan Sayyah, Hüseyin Tunç, et al. · Journal of Chemical Information and Modeling · 1
Kroni̇k Lenfosi̇ti̇k Lösemi̇ Tanili Hastalarda Ki̇ller İmmünoglobuli̇n Li̇ke Reseptör Gen Düzeyleri̇ Ve Otoi̇mmün Olaylar İle İli̇şki̇si̇
2021 · Mustafa Özbalak, Işıl Erdoğan Özünal, et al. · Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi · 1
PDF
Selinexor enhances temozolomide efficacy in glioblastoma through modulation of multiple resistance-associated mechanisms
2026 · Beyza Ozturk, Asuman Celebi, et al. · Frontiers in Oncology
PDF
Disrupting Redox Balance: A Redox-Based Strategy to Combat Temozolomide Resistance in Glioblastoma
2026 · Asuman Celebi, Turker Kilic, et al. · Anti-Cancer Agents in Medicinal Chemistry
Machine learning-driven discovery of potent isocitrate dehydrogenase 1 mutant inhibitors from ultralarge ligand libraries for targeting malignant glioma
2026 · Mehreen Zaka, Fareed Asaad, et al. · Journal of Pharmacology and Experimental Therapeutics
Abstract LB021: BAU-243: A novel BCL-2 inhibitor inducing autophagic cell death in glioblastoma, unveiled through multistep virtual screening, comprehensive in vitro and in vivo animal model evaluation
2024 · Seyma Calis, Berna Dogan, et al. · Cancer Research
Stk11 and prkaca gene expressions in benign & malignant prostate diseases
2019 · H. Köseoğlu, N. Dalay, et al. · European Urology Supplements
Abstract B33: The role of WWOX in HNSCC through Wnt/beta-catenin pathway
2017 · Ayse Nur Buyru, Asuman Celebi, et al. · Cancer Research
Works count: 16
Citation count: 77
H-index: 4
I10-index: 2
Year
Topic
Type